– IRELAND, Oranmore – Mirai Medical, a cutting-edge medical technology start-up and leader in Pulsed Field Ablation within the Gastrointestinal Tract, today announced the appointment of David Pierce to its Board as a Non-Executive Director, bringing a wealth of experience and industry insight to the Board.
About David A. Pierce
.David Pierce was EVP and President of MedSurg and president of Endoscopy at Boston Scientific. His distinguished career at Boston Scientific, spanning 31 years, has been marked by numerous accomplishments and a deep understanding of the MedTech landscape. His expertise in product commercialization, market access, and clinical change management in the Gastrointestinal Endoscopy space positions him as a valuable addition to Mirai Medical’s leadership team.
David Pierce said, “I am honoured to be part of Mirai Medical, a company at the forefront of innovation in interventional endoscopy. The mission to enable every endoscopist to treat at diagnosis resonates strongly with me, and I look forward to contributing to the company’s growth and success.”
About Mirai Medical
Mirai Medical is a leading MedTech start-up specializing in Pulsed Field Ablation within the Gastrointestinal Tract. Our mission is to empower every endoscopist to treat at diagnosis, revolutionizing patient care. Its proprietary ePORE therapy is uniquely designed with precise algorithmic control of PFA parameters enabling the safe and effective treatment of both pre-malignant and malignant disease across the entire gastrointestinal tract. Mirai Medical is headquartered in Galway, Ireland.
For more information: https://mirai-medical.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
